摘要
目的分析影响产妇剖宫产后出血的危险因素及葡萄糖酸钙和米索前列醇联合使用对产妇出血预防的疗效观察。方法选择2019年1月-2021年7月收治的82例产妇进行研究,其中巨大儿30例,羊水过多8例,双胎妊娠4例,瘢痕子宫20例,多产及其他20例。采用随机数表法进行分组,均分为观察组(41例,葡萄糖酸钙联合米索前列醇)与对照组(41例,未用药)。分析对患者临床疗效、出血情况、生命体征、影响产妇产后出血的相关危险因素。结果临床疗效对比(P<0.05);出血情况对比(P<0.05);生命指标对比(P<0.05);其中巨大儿、子宫收缩乏力为导致产妇产后出血的独立因素(P<0.05)。结论米索前列醇联合葡萄糖酸钙可显著提高对患者临床疗效,可提高对产妇产后出血危险因素的预防效果,降低产后出血率,值得广泛推广。
Objective To analyze the risk factors of bleeding after cesarean section and observe the effect of calcium gluconate and Misoprostol on the prevention of bleeding.Methods A total of 82 parturients from January 2019 to July 2021 were selected for the study,including 30 cases of macrosomia,8 cases of polyhydramnios,4 cases of twin pregnancy,20 cases of scarred uterus,prolificacy and other 20 cases.Groups were grouped by random number table,and they were divided into observation group(41 cases,calcium gluconate combined with Misoprostol)and control group(41 cases,no medication).Analyze the clinical efficacy,bleeding status,vital signs,and related risk factors that affect the postpartum hemorrhage of the parturient.Results Comparison of clinical efficacy(P<0.05).Comparison of bleeding(P<0.05).Comparison of vital indicators(P<0.05).Among them,macrosomia and uterine weakness are independent factors that cause postpartum hemorrhage(P<0.05).Conclusion The combination of Misoprostol and calcium gluconate can significantly improve the clinical efficacy of patients,improve the prevention effect on the risk factors of postpartum hemorrhage,and reduce the rate of postpartum hemorrhage.It is worthy of widespread promotion.
作者
董丽娟
DONG Lijuan(Lianyungang Sheng'an Hospital,Lianyungang,Jiangsu 222100)
出处
《智慧健康》
2022年第8期58-60,共3页
Smart Healthcare
